Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience()

BACKGROUND: The effect of chemotherapy in metastatic bone sarcomas is poor and the condition is invariably fatal. Therefore, new treatment modalities are intensely needed. Pazopanib is a selective multitargeted tyrosine kinase inhibitor that has proven to be effective in the treatment of metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggerholm-Pedersen, Ninna, Rossen, Phillip, Rose, Hanne, Safwat, Akmal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931211/
https://www.ncbi.nlm.nih.gov/pubmed/31875575
http://dx.doi.org/10.1016/j.tranon.2019.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931211/
https://www.ncbi.nlm.nih.gov/pubmed/31875575
http://dx.doi.org/10.1016/j.tranon.2019.12.001

Ejemplares similares